Ticker Details
Oramed Pharmaceuticals Inc. Oramed Pharmaceuticals Inc is a pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet.
IPO Date:	May 1, 2007
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$200.08M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.23 | 3.27%
Avg Daily Range (30 D):	$0.10 | 2.42%
Avg Daily Range (90 D):	$0.13 | 3.08%

Institutional Daily Volume
Avg Daily Volume:	.26M
Avg Daily Volume (30 D):	.15M
Avg Daily Volume (90 D):	.2M

Trade Size
Avg Trade Size (Sh.):	160
Avg Trade Size (Sh.) (30 D):	71
Avg Trade Size (Sh.) (90 D):	78

Institutional Trades
Total Institutional Trades:	117
Avg Institutional Trade:	$1.78M
Avg Institutional Trade (30 D):	$7.49M
Avg Institutional Trade (90 D):	$7.49M
Avg Institutional Trade Volume:	.21M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.68M
Avg Closing Trade (30 D):	$14.12M
Avg Closing Trade (90 D):	$14.12M
Avg Closing Volume:	372.95K

News

Jun 17, 2026 @ 12:55 PM Oramed Pharmaceuticals to Join Russell 2000® an... Source: Prnewswire

Mar 13, 2026 @ 12:00 PM Lifeward Receives Shareholder Approval to Close on... Source: Na

Jan 7, 2026 @ 1:55 PM Oramed Receives $18 Million Payment from Scilex Ho... Source: Prnewswire

Nov 17, 2025 @ 1:50 PM ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DIST... Source: Prnewswire

Feb 11, 2025 @ 2:15 PM Oramed Announces Transformative Joint Venture to A... Source: Prnewswire

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$4.24	$1.9	$.95
Diluted EPS	$4.13	$1.84	$.92
Revenue
Gross Profit
Net Income / Loss	$174.86M	$78.16M	$38.31M
Operating Income / Loss	$-14.52M	$-2.77M	$-3.66M
Cost of Revenue
Net Cash Flow	$-.55M
PE Ratio

Splits
Jan 23, 2013	1:12